Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Acta Neurochir (Wien) ; 150(11): 1183-91, 2008 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-18936876

RESUMO

BACKGROUND: Chordoid glioma is a rare tumour (World Health Organisation grade II) originating from the third ventricle with both glial and chordoid features. It was first described by Brat in 1998. Since there is no detailed information available on the outcome after surgery and adjuvant treatment, we reviewed the literature. METHODS: A literature search through PUBMED revealed 50 cases of chordoid glioma. Most reports were found in pathology journals. Information on the postoperative course was sometimes very limited. We reviewed the available literature and studied in detail the presenting symptoms, mortality and postoperative complications in relation to the extent of resective surgery, as well as the importance of adjuvant treatment. CONCLUSIONS: Mortality in the immediate postoperative period is 32% and is higher after gross total resection as compared to subtotal resection. Non-fatal postoperative complications are hypothalamic disorders and mental alterations. Gross total resection is the treatment of choice since no recurrence has been reported after macroscopically complete resection, but this is often difficult because of the location and adherence to the hypothalamus. The role of postoperative radiotherapy is uncertain. There is some indication that radiosurgery with or without conventional irradiation is superior to conventional radiation alone. Planned subtotal resection followed by stereotactic radiosurgery can be a safe and effective alternative in a patient in whom gross total resection is considered to be too risky. There is no report on the use of chemotherapy in the treatment of chordoid gliomas. More information about the optimal treatment strategy is needed, and more reports are also needed.


Assuntos
Neoplasias do Ventrículo Cerebral/patologia , Neoplasias do Ventrículo Cerebral/cirurgia , Glioma/patologia , Glioma/cirurgia , Terceiro Ventrículo/patologia , Neoplasias do Ventrículo Cerebral/complicações , Feminino , Glioma/complicações , Humanos , Doenças Hipotalâmicas/etiologia , Doenças Hipotalâmicas/patologia , Doenças Hipotalâmicas/fisiopatologia , Masculino , Invasividade Neoplásica/patologia , Invasividade Neoplásica/fisiopatologia , Procedimentos Neurocirúrgicos/efeitos adversos , Procedimentos Neurocirúrgicos/métodos , Procedimentos Neurocirúrgicos/mortalidade , Complicações Pós-Operatórias/mortalidade , Complicações Pós-Operatórias/fisiopatologia , Radiocirurgia/métodos , Radiocirurgia/normas , Distribuição por Sexo , Terceiro Ventrículo/fisiopatologia , Terceiro Ventrículo/cirurgia
2.
Acta Neurochir (Wien) ; 146(8): 851-6, 2004 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-15254808

RESUMO

We are reporting a case of an immunocompromised patient with invasive aspergillosis (IA) who developed aspergillotic granulomas and a mycotic aneurysm of the superior cerebellar artery. The route of infection of the central nervous system (CNS) was hematogenous spread from a pulmonary focus. IA was detected with the Galactomannan (GM) technique. However, despite treatment with amphotericin B, progressive involvement of the vessel wall occurred causing fatal subarachnoid hemorrhage and massive brainstem and cerebellar infarction. This case provides pathologic-imaging correlation of one of the most devastating types of fungal involvement affecting the CNS with a fungal aneurysm. Finally the literature regarding the pathogenetic, and diagnostic investigations and the management of CNS aspergillosis is reviewed.


Assuntos
Aspergillus fumigatus , Infarto Encefálico/microbiologia , Granuloma/microbiologia , Aneurisma Intracraniano/microbiologia , Neuroaspergilose/complicações , Evolução Fatal , Humanos , Masculino , Pessoa de Meia-Idade , Neuroaspergilose/diagnóstico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...